HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$47.67
Day range
$45.52 - $49.81
Year range
$3.35 - $54.10
Market cap
303.65M USD
Avg Volume
34.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.23M | 80.81% |
Net income | -2.45M | -43.04% |
Net profit margin | — | — |
Earnings per share | -0.35 | 30.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.25M | 648.03% |
Total assets | 53.87M | 650.24% |
Total liabilities | 1.66M | 52.73% |
Total equity | 52.20M | — |
Shares outstanding | 6.17M | — |
Price to book | 5.59 | — |
Return on assets | -14.84% | — |
Return on capital | -15.27% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.45M | -43.04% |
Cash from operations | -1.08M | 35.75% |
Cash from investing | 1.19M | 49,100.99% |
Cash from financing | -316.84K | -3,094.32% |
Net change in cash | -209.47K | 87.59% |
Free cash flow | -693.36K | 35.28% |
About
Founded
2014
Headquarters
Website
Employees
16
